Oxidative modification of cysteine 111 promotes disulfide bond-independent aggregation of SOD1

Neurochemical Research

Volumn 37, Issue 4, 2012, Pages 835-845

  Chen, Xueping ^a   Shang, Huifang ^b   Qiu, Xiaozhong ^a,c   Fujiwara, Noriko ^d   Cui, Liying ^e   Li, Xin Min ^f   Gao, Tian Ming ^c   Kong, Jiming ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b SICHUAN UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e Beijing Union Hospital   (China)

^f UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Amyotrophic lateral sclerosis; Copper zinc superoxide dismutase; Cysteine 111; Oxidative modification

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYSTEINE; THIOL GROUP;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISULFIDE BOND; ENZYME MODIFICATION; FEMALE; MALE; MOUSE; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PEROXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN POLYMERIZATION; RAT;

ANIMALS; CYSTEINE; DISULFIDES; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MUTATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PC12 CELLS; RATS; SUPEROXIDE DISMUTASE;

MUS MUSCULUS;

EID: 84862862329     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0679-8     Document Type: Article

References (37)

1. Friedlander RM (2003) Apoptosis and caspases in neurodegen-erative diseases. N Engl J Med 348:1365-1375 (Pubitemid 36384105)
2. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H et al (2004) A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 47:263-274 (Pubitemid 39574324)
3. Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2:806-819 (Pubitemid 33674062)
4. Andersen PM, Sims KB, Xin WW, Kiely R, O'Neill G et al (2003) Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 4:62-73 (Pubitemid 36874774)
5. Cleveland DW (1999) From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 24:515-520
6. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ et al (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43-47 (Pubitemid 26139292)
7. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD et al (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281:1851-1854 (Pubitemid 28450505)
8. Ross CA, Poirier MA (2005) Opinion: what is the role of protein aggregation in neurodegeneration? Natl Rev Mol Cell Biol 6:891-898 (Pubitemid 41568738)
9. Kabashi E, Valdmanis PN, Dion P, Rouleau GA (2007) Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Ann Neurol 62:553-559
10. Uchida K, Kawakishi S (1994) Identification of oxidized histidine generated at the active site of Cu, Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. J Biol Chem 269:2405-2410
11. Kurahashi T, Miyazaki A, Suwan S, Isobe M (2001) Extensive investigations on oxidized amino acid residues in H(2)O(2)-treated Cu, Zn-SOd protein with LC-ESI-Q-TOF-MS, MS/MS for the determination of the copper-binding site. J Am Chem Soc 123:9268-9278 (Pubitemid 32900300)
12. Rakhit R, Crow JP, Lepock JR, Kondejewski LH, Cashman NR et al (2004) Monomeric Cu, Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol Chem 279: 15499-15504 (Pubitemid 38618950)
13. Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF et al (2002) Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem 277:47551-47556 (Pubitemid 36159274)
14. Casoni F, Basso M, Massignan T, Gianazza E, Cheroni C et al (2005) Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis. J Biol Chem 280:16295-16304 (Pubitemid 40616757)
15. Furukawa Y, Torres AS, O'Halloran TV (2004) Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J 23:2872-2881 (Pubitemid 39013559)
16. Ezzi SA, Urushitani M, Julien JP (2007) Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem 102:170-178 (Pubitemid 46906269)
17. Di Noto L, Whitson LJ, Cao X, Hart PJ, Levine RL (2005) Proteasomal degradation of mutant superoxide dismutases linked to amyotrophic lateral sclerosis. J Biol Chem 280:39907-39913 (Pubitemid 41779125)
18. Makmura L, Hamann M, Areopagita A, Furuta S, Munoz A et al (2001) Development of a sensitive assay to detect reversibly oxidized protein cysteine sulfhydryl groups. Antioxid Redox Signal 3:1105-1118 (Pubitemid 34027366)
19. Zhang F, Strom AL, Fukada K, Lee S, Hayward LJ et al (2007) Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J Biol Chem 282:16691-16699 (Pubitemid 47100405)
20. Parge HE, Hallewell RA, Tainer JA (1992) Atomic structures of wild-type and thermostable mutant recombinant human Cu, Zn superoxide dismutase. Proc Natl Acad Sci USA 89:6109-6113
21. Jacob C, Holme AL, Fry FH (2004) The sulfinic acid switch in proteins. Org Biomol Chem 2:1953-1956
22. Fujiwara N, Nakano M, Kato S, Yoshihara D, Ookawara T et al (2007) Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase. J Biol Chem 282:35933-35944 (Pubitemid 350277101)
23. Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F et al (2010) Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13:1396-1403
24. Urushitani M, Kurisu J, Tsukita K, Takahashi R (2002) Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J Neurochem 83:1030-1042 (Pubitemid 35397113)
25. Oeda T, Shimohama S, Kitagawa N, Kohno R, Imura T et al (2001) Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans. Hum Mol Genet 10:2013-2023 (Pubitemid 32998814)
26. Niwa J, Yamada S, Ishigaki S, Sone J, Takahashi M et al (2007) Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J Biol Chem 282:28087-28095 (Pubitemid 47529492)
27. Furukawa Y, Fu R, Deng HX, Siddique T, O'Halloran TV (2006) Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice. Proc Natl Acad Sci USA 103:7148-7153
28. Cozzolino M, Amori I, Pesaresi MG, Ferri A, Nencini M et al (2008) Cysteine 111 affects aggregation and cytotoxicity of mutant Cu, Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. J Biol Chem 283:866-874
29. Karch CM, Borchelt DR (2008) A limited role for disulfide crosslinking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem 283:13528-13537
30. Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR (2009) Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci USA 106:7774-7779
31. Krishnan U, Son M, Rajendran B, Elliott JL (2006) Novel mutations that enhance or repress the aggregation potential of SOD1. Mol Cell Biochem 287:201-211 (Pubitemid 44057408)
32. Son M, Puttaparthi K, Kawamata H, Rajendran B, Boyer PJ et al (2007) Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc Natl Acad Sci USA 104:6072-6077 (Pubitemid 47175660)
33. Gruzman A, Wood WL, Alpert E, Prasad MD, Miller RG et al (2007) Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 104:12524-12529 (Pubitemid 47206171)
34. Ferri A, Cozzolino M, Crosio C, Nencini M, Casciati A et al (2006) Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc Natl Acad Sci USA 103:13860-13865 (Pubitemid 44413998)
35. Deng HX, Shi Y, Furukawa Y, Zhai H, Fu R et al (2006) Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci USA 103:7142-7147
36. Goldsteins G, Keksa-Goldsteine V, Ahtoniemi T, Jaronen M, Arens E et al (2008) Deleterious role of superoxide dismutase in the mitochondrial intermembrane space. J Biol Chem 283: 8446-8452
37. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 92:689-693